Earth Science Tech Expands Into New Verticals With Zoolzy Acquisition

Earth Science Tech Inc. (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, has completed the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. Based in Doral, Florida, Zoolzy operates from a 3,684-square-foot facility, and its acquisition is set to deliver value across three key growth drivers: expanding overall profit margins, broadening access to new ingredients, and enabling entry into the veterinary market.

The acquisition is a strategic move by Earth Science Tech to seize opportunities that broaden its telehealth and pharmacy fulfillment platforms into new, complementary verticals. By integrating Zoolzy's distribution capabilities, ETST's compounding pharmacies can secure essential raw materials at highly competitive wholesale pricing, significantly increasing the company's overall profit margins. This vertical integration allows for better cost control and supply chain efficiency, which are critical in the competitive pharmaceutical landscape.

Furthermore, the acquisition expands ETST's access to a wider array of active pharmaceutical ingredients, facilitating the development and production of a broader range of compounded medications. This is particularly important in the growing field of personalized medicine, where access to diverse APIs is essential for tailoring treatments to individual patient needs. With Zoolzy's established supplier networks, ETST can enhance its product offerings and responsiveness to market demands.

One of the most promising aspects of this acquisition is the entry into the veterinary market. Veterinary pharmaceuticals represent a significant and underserved segment, with increasing demand for compounded medications for pets and livestock. By leveraging Zoolzy's distribution channels and regulatory expertise, ETST can tap into this lucrative market, diversifying its revenue streams and reducing reliance on the human pharmaceutical sector alone. This move aligns with broader industry trends toward pet humanization and increased spending on animal health.

The acquisition also underscores ETST's commitment to growth through strategic acquisitions that create synergies with its existing operations. As a holding company, ETST aims to build a diversified portfolio of healthcare-related businesses that can cross-sell and support each other. Zoolzy's distribution capabilities not only benefit ETST's compounding pharmacies but also position the company to serve other healthcare providers and institutions seeking reliable API sources.

Investors are likely to view this acquisition favorably, as it demonstrates management's proactive approach to enhancing shareholder value through operational improvements and market expansion. The integration of Zoolzy is expected to contribute to ETST's top and bottom lines in the near term, while the veterinary market entry offers long-term growth potential.

For more information on Earth Science Tech and its latest developments, visit the company's newsroom at https://ibn.fm/ETST. The acquisition was detailed in a press release, which is available at this link.